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Background: To describe reported studies of the impact on HbA1C levels, diabetes-related hospitalisations, and
other primary care health endpoints of initiatives aimed at improving the management of diabetes in Indigenous
adult populations of Australia, Canada, New Zealand and the United States.
Method: Systematic literature review using data sources of MEDLINE, Embase, the Cochrane Library, CINHAL and
PsycInfo from January 1985 to March 2012. Inclusion criteria were a clearly described primary care intervention,
model of care or service, delivered to Indigenous adults with type 2 diabetes reporting a program impact on at
least one quantitative diabetes-related health outcome, and where results were reported separately for Indigenous
persons. Joanna Briggs Institute critical appraisal tools were used to assess the study quality. PRISMA guidelines
were used for reporting.
Results: The search strategy retrieved 2714 articles. Of these, 13 studies met the review inclusion criteria. Three levels of
primary care initiatives were identified: 1) addition of a single service component to the existing service, 2) system-level
improvement processes to enhance the quality of diabetes care, 3) change in primary health funding to support better
access to care. Initiatives included in the review were diverse and included comprehensive multi-disciplinary diabetes care,
specific workforce development, systematic foot care and intensive individual hypertension management. Twelve studies
reported HbA1C, of those one also reported hospitalisations and one reported the incidence of lower limb amputation.
The methodological quality of the four comparable cohort and seven observational studies was good, and moderate for
the two randomised control trials.
Conclusions: The current literature provides an inadequate evidence base for making important policy and practice
decisions in relation to primary care initiatives for Indigenous persons with type 2 diabetes. This reflects a very small
number of published studies, the general reliance on intermediate health outcomes and the predominance of
observational studies. Additional studies of the impacts of primary care need to consider carefully research design and the
reporting of hospital outcomes or other primary end points. This is an important question for policy makers and further
high quality research is needed to contribute to an evidence-base to inform decision making.
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Type 2 diabetes (T2DM) is a chronic health condition
that affects a significant and growing proportion of the
global population. In 2013, an estimated 8.3% of world’s
population aged 20 to 79 years had diabetes [1]. For the
same period and age group, diabetes prevalence in
Australia, Canada and the United States (US) was 10%,
10.2% and 10.9% respectively [1] and 8.1% in New Zealand
(NZ) in 2011 [2]. By the year 2030 type 2 diabetes preva-
lence among the global population aged 20 to 79 years has
been forecasted to increase by 69% in developing countries
and 20% in developed countries [3]. These prevalence rates
are average figures based on the total population and it is
well established that prevalence of diabetes varies by popu-
lation groups.
The evidence shows that the majority of the world’s
Indigenous populations have been experiencing a more
rapid increase in type 2 diabetes prevalence than their
non-Indigenous counterparts [4]. This is the case in
Australia, NZ, Canada and the US, all high income
OECD countries [2] with well-established primary health
care (PHC) systems, that for Indigenous populations are
largely publicly funded. Whilst these populations have
diverse cultures, languages and practices both within
and between them which may warrant differences in in-
terventions, there are also commonalities [5]. The Indi-
genous populations in these four countries have a shared
history of colonisation that includes being displaced
from their traditional lands which effectively removed
their access to all known resources [6]. This has had
devastating and lasting effects, that present in the
current health disparities experienced by these Indigen-
ous populations. These populations are all minority
groups within their country and their population growth
is faster than that of their non-Indigenous counter parts
[5]. They all suffer poorer health outcomes and poorer
social determinants of health than their non-Indigenous
counterparts; and experience the on-set of type 2 dia-
betes at an earlier age and higher related morbidity and
mortality [5].
Australia, NZ, Canada and the US are responding to
this diabetes epidemic through policies that support
mainstream and Indigenous specific health services to
increase access to and quality of health care for Indigen-
ous people. Primary health care services are recognised
by the World Health Organisation as best positioned
within the health system to detect and manage chronic
diseases, including diabetes, from both an access and an
economic perspective [7]. Chronic disease detection and
management, although at different stages of implemen-
tation, are well embedded in the primary care setting in
these high income countries [7].
It is necessary to manage diabetes well to prevent or
slow the onset of related vascular damage, includingcardiovascular [8] and kidney diseases [9]. The aim is to
bring clinical risk factors to within the normal range to
reduce the risk of diabetes-related vascular complica-
tions and mortality [10]. Large US and UK-based clinical
trials, have demonstrated that raised HbA1c and blood
pressure can be lowered, and poor blood lipid profiles
improved, using structured treatment protocols [11].
However, despite evidence from randomised control tri-
als (RCTs) of the benefits of intense diabetes manage-
ment, care in the clinical practice setting still often
departs from best practice, contributing to the poorer
than expected health outcomes and higher health care
costs [12,13]. Evidence linking better health outcomes
with reduced hospital admission is also inconsistent, es-
pecially in real clinic settings [14,15].
In order to guide future policy to improve outcomes
for persons with diabetes, especially for Indigenous pop-
ulations—for whom prevalence of T2DM is highest and
outcomes poorest—it is important to know the system
level attributes that may contribute to the better man-
agement of type 2 diabetes in the primary care setting.
The objective of this study was to assess the impact of
PHC initiatives on health outcomes of Indigenous
people in Australia, NZ, Canada and the US with




Participants were Indigenous adults with T2DM of
Australia, NZ, Canada, or the US who have received dia-
betes management in a PHC setting. For the purpose of
this review a PHC setting was defined as the provision of
diabetes-related clinical care in the community, with the
aim of preventing or reducing acute diabetes complica-
tions and/or diabetes-related vascular disease progression.
A PHC intervention, model of care or service needed to
be described and evaluated. This could include: i) the
addition of a new service model incorporated into the
local PHC service, for example, an outreach home visiting
nurse providing individual hypertension management; ii) a
system level quality improvement (QI) process to enhance
the quality of diabetes care, for example, implementing
evidence based diabetes care guidelines and support sys-
tems with related workforce development; or iii) a change
in PHC funding/incentives, typically designed to increase
access to care and/or support better quality care, for ex-
ample, government reimbursement for completion of an-
nual diabetes health check items. The study had to report
a quantitative diabetes-related outcome; of HbA1c,
diabetes-related hospitalisation and/or a diabetes-related
health outcome. These outcome measures were chosen
because HbA1c is the agreed indicator of individual
glycemic control [16]. Unplanned diabetes-related hospital
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primary care service is performing [17]. Diabetes-
related health outcomes such as lower limb amputation,
renal failure (i.e. chronic renal disease and end-stage
renal disease) and cardiovascular complications (i.e.
coronary heart disease, heart failure and peripheral vas-
cular disease) are also measures of access to, and qual-
ity of, PHC. In multi-ethnicity studies the results for
Indigenous persons had to be reported separately.
Study designs that were included for full quality assess-
ment and data extraction were RCT, cluster rando-
mised trials, pre and post cohort studies or multivariate
analysis of cross sectional or longitudinal data.
Search strategy
Medline, Embase, CINAHL and PsychINFO databases
were searched. Search terms were identified using the
map term search tool for Indigenous population groups
of the four countries—Australia, NZ, Canada and the
US—and T2DM. Search terms applied in Medline were
Health Services OR indigenous people$ OR aborigin$
OR native born OR native people$ OR torres strait is-
land$ OR American Indian$ OR native American$ OR
Canadian Indian$ OR maori$ OR eskimo$ OR aleut$
OR nuit$ OR first nation OR pima OR cree OR chero-
kee OR American native$ OR American native contin-
ental ancestry group OR central American$ OR north
American$ OR south American$ NOT Asian NOT
brazil$ NOT latin$ AND exp *diabetes mellitus, experi-
mental/or exp *diabetes mellitus, type 2/ OR (‘diabet$’
or ‘diabet$ complication$’) OR (non insulin dependent
diabetes mellitus or diabetes mellitus type 2 or diabetes
mellitus type ii or diabetes mellitus, non-insulin-
dependent or dm2 or niddm or noninsulin dependent
diabetes or noninsulin dependent diabetes mellitus or
type 2 diabetes mellitus) OR (maturity onset diabetes
mellitus or adult onset diabetes or adult onset diabetes
mellitus or diabetes mellitus, maturity onset or diabetes,
adult onset or maturity onset diabetes) NOT IDDM
NOT insulin dependent diabetes mellitus NOT type 1
diabetes mellitus NOT child$ NOT maternal NOT preg-
nan$ NOT prevalence. Terms were searched for in the
article title, abstract, substance word, subject heading
and key words. The Cochrane library was searched for
systematic review articles only. The search covered the
time period from January 1985, to ensure evidence-
based care model interventions were captured [18], to
March 2012. A reference search was performed on in-
cluded articles.
Study selection
To determine eligibility for inclusion article titles were
reviewed by author OG. Abstracts of eligible study titles
were independently reviewed. Authors OG and LSreviewed 50 abstracts. OG and a colleague (DH)
reviewed the remaining 88 abstracts. When agreement
on eligibility for inclusion could not be reached by OG
and DH, LS was consulted. Full manuscripts were
reviewed by OG against the inclusion criteria and pos-
sible exclusions were discussed with LS to reach
agreement. Templates developed by OG were used to
record the assessment of each study against the eligi-
bility criteria during the abstract review and the full
article review.
Assessment of methodological quality
Standardised critical appraisal tools, appropriate to the
study design, were used to assess the methodological of
articles that met the study inclusion criteria [19].
Data collection
Data were extracted from included studies covering the
characteristics of the study population, the PHC initia-
tives, the study design, quality and outcomes.
Results
The electronic search identified 2714 articles, of which
after initial screening, 51 full articles were reviewed. See
Figure 1 for search outcomes. In total 13 articles met the
inclusion criteria. Reasons for exclusion were, ineligible
study population, no primary health care intervention
implemented, did not report HbA1C/hospitalisation or
health outcome, and results for Indigenous people were
not report separately.
A brief description of each included study is as
follows:
Australian Coordinated Care Trials – late 1998 (Bailie
et al. 2004) [20]
Were conducted in two remote regions of the
Northern Territory (NT); 1) Katherine West, which
includes a township, several large communities and
outstations and an Aboriginal population of
approximately 3000; 2) the Tiwi Islands which has an
Aboriginal population of approximately 1800 of a total
of 2000. The CCT increased total primary care funds
and facilitated the transfer of funds to local Indigenous
health management boards for the purchase and
delivery of health services. In addition, the trial
increased the local Aboriginal health care workforce
through access to certified training, and introduced
clinical systems for providing systematic access to
evidence-based chronic disease care. It commenced in
late 1998 and ran for approximately two years. Results
were presented up to three years post baseline data
collection. Bailie and colleagues identified trends in
diabetes processes of care and patient health outcomes
before and after the trial at both locations.
Figure 1 Flowchart diagram.
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2007) [21]
A QI intervention was implemented between 2002 and
2005 in 12 PHC centres in the NT top end. The QI
intervention included staff orientation and a conference
to enhance understanding of the QI process (i.e. use of
assessments and audits of clinical outcomes). The
results informed the development of action plans, and
facilitated sharing of progress across health centres.
Bailie and colleagues explored system-related barriers
and facilitators to improvements in outcomes of care
by two means of assessment using their modified
version of the Assessment of Chronic Illness Care
Scale. They assessed 1) health system change and 2)diabetes quality of care by processes of care performed
compared to clinical guideline recommendations and
health outcomes by medical chart audit.
Indian Health Service United States (Wilson et al.
2005; Roubideaux et al. 2008; Ramesh et al. 2008;
Schraer et al. 2003) [22-25]
The IHS is funded by the US Government to assist
American Indian and Alaskan Native tribes establish
and expand local PHC programs and diabetes teams.
The diabetes initiatives of the IHS include increasing
access to glucose monitoring supplies among American
Indian and Alaskan Native communities, establishing a
diabetes population register and operating a regional
diabetes specialist referral centre. Wilson and
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provided by the IHS for the period 1995–2001.
Integrated Diabetes Education Recognition Program
(IDERP) ranked IHS programs according to the
comprehensiveness of PHC services provided. Level 3
ranking is the highest and is given to IHS services that
deliver educational, clinical and public health programs.
Only a level 3 ranking service is eligible to receive
Medicare reimbursement for services performed.
Roubideaux and colleagues [23] examined the
association between the level of diabetes education
program assigned by the IDERP (i.e. developmental and
education and integrated combined) and the quality
diabetes of care by the number of care items
completed, such as eye examination, dental check,
yearly education, and laboratory tests performed, across
the 138 IHS sites.
The Special Diabetes Program for Indians comprises
multi-disciplinary diabetes teams that support the
implementation of evidence based care guidelines and
QI processes in IHS hospitals, regional health centres
and tribal clinics. The program receives referrals from
all IHS facilities and maintains a regional diabetes
register. Ramesh and colleagues [24] assessed the
quality of care delivered by the Special Diabetes
Program for Indians by measuring the processes of
evidence-based care achieved and patient health
outcomes of 1394 participants, using a pre and post
study design.
The High Risk Foot Program devised a diabetic foot
risk categorisation system and maintained a register of
high-risk patients with diabetes for all IHS facilities.
Specialist foot care outreach services were provided
from the centre, which included training local health
staff in foot care. Schraer and colleagues [25] compared
the incidence of lower extremity amputation three
years pre and three years post introduction of the High
Risk Foot program.
Care Plus – NZ (Kenealy et al. 2010) [26]
An overall aim of Care Plus was to reduce health
outcome inequalities between Maori and non-Maori.
Launched as a QI initiative, NZ Government funding was
available to PHC organisations to develop a wellness plan
for all patients and employ nurse consultants to assist with
diabetes management. Kenealy and colleagues conducted
a pre and post cohort study to determine if the Care Plus
initiative implemented by the Manaia PHO resulted in
similar levels of glycemic control for Maori (n = 357) and
non-Maori (n = 957) during July 2005 to August 2007.
Get Checked – NZ (Smith et al. 2011) [27]
The Get Checked program met patient costs of an
annual diabetes review by reimbursing general
practitioners (GPs) or practice nurses for completed
diabetes care plans delivered in accordance withevidence-based care guidelines. Smith and colleagues
conducted a longitudinal study, with a cohort of 295
people with T2DM in the Wellington Region of NZ,
to investigate clinical outcomes over five annual visits
during 2000 to 2006. A separate analysis was
completed with Maori patients.
Integrated diabetes specialist clinic – Australia
(Simmons et al. 2003) [28]
Simmons et al reported on the effectiveness of an
integrated diabetes service in an Aboriginal Medical
Service in rural Victoria. A weekly specialist diabetes
clinic was integrated with the local PHC service. In
between the weekly diabetes specialist visits, the local
PHC team provided patient follow-up care. A
retrospective audit of attendance at the clinic was
linked to intermediate health outcomes of 47 patients
with T2DM.
Patient recall system to support evidence based
guidelines for diabetes – Australia (McDermott et al.
2001) [29]
Evidence-based guidelines for diabetes were provided to
21 PHC centres managed by Indigenous health workers
in the Torres Strait Islands. In eight randomly
identified intervention sites a paper-based diabetes
recall system was established and staff training provided
on the use of the system and basic diabetes care.
McDermott and colleagues compared health indicators
and hospitalisations collected at baseline (December
1998 to February 1999) and follow-up (March to April
2000) within and between the intervention and control
sites. The aim was to determine if the diabetes recall
system managed by local health workers improved the
quality of diabetes care to patients and resulted in fewer
diabetes-related hospitalisations.
Diabetes Risk Evaluation And Macroalbuminuria 3 –
Canada (Tobe et al. 2006) [30]
DREAM 3 was the third study in response to the
Battlefords Tribal Council to identify the prevalence of
end stage renal failure in remote Saskatchewan
communities. The study was an RCT focused on
hypertension management. The intervention group of
50 participants received a nurse practitioner and local
health worker managing and adjusting blood pressure
control during regular home visits. The control group
of 49 participants maintained usual GP care. Tobe and
colleagues evaluated the effect of the community-based
home visiting program on blood pressure control.
Diabetes Outreach Van Enhancement program - Canada
(Ralph-Campbell et al. 2006) [31]
Promoting best practice guidelines and professional
development of local health care professionals in
diabetes care was the aim of the DOVE program. It
was a regional-based specialist diabetes outreach team
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examined clinical differences between Aboriginal and
non-Aboriginal Canadians who participated in the
DOVE program, using a pre – post cohort design.
There was no comparison group.
Screening for Limb, I-Eye, Cardiovascular and
Kidney (SLICK) complications – Canada (Virani
et al. 2006) [32]
A mobile outreach service provided by specialist staff
screened for micro and macro-vascular complications
of diabetes in Canadian First Nations people in
Alberta. Its main aim was to support implementation
of Canada’s clinical practice guidelines for diabetes
through delivery of the outreach service and professionalble 1 Methodological appraisal of studies
mparable cohort/case control studies
rst author (Year) Q1 Q2 Q3
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alyses used?.development of local health staff. Virani and colleagues
evaluated the program.
The methodological quality of the four comparable co-
hort and seven observational studies was good and mod-
erate for the two RCT (Table 1).
Four initiatives were located in Australia [20,21,28,29],
three in Canada [30-32], two in NZ [26,27] and four in
the US [22-25]. Ten initiatives were multifaceted with a
focus on improving the quality and coordination of clin-
ical care, increasing access to care and professionally de-
veloping the local workforce [20-26,28,29,32]. Three
initiatives supported local health care providers to de-
liver optimum care [27,30,31]. Five of the 13 initiatives
facilitated health system investment [20,22,23,26,27]. SixQ4 Q5 Q6 Q7 Q8 Q9
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red in statistical models.
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reliable way? 9) Was appropriate statistical analysis used?
ple? 2) Were the criteria for inclusion in the sample clearly defined? 3) Were
tcomes assessed using objective criteria? 5) If comparisons are being made,
sufficient time period? 7) Were the outcomes of people who withdrew
ay? 9) Was appropriate statistical analysis used?
andom? 2) Were participants blinded to treatment allocation? 3) Was allocation
who withdrew described and included in the analysis 5) Were those assessing
ps comparable at entry? 7) Were groups treated identically other than for the
9) Were outcomes measured in a reliable way? 10) Was appropriate statistical
Gibson and Segal BMC Health Services Research  (2015) 15:154 Page 7 of 13initiatives invested in building the capacity of the clinical
system [21,24,25,28,29,32]. Two initiatives were new
models of care [30,31]. Governance of the PHC services
involved in the 13 primary care initiatives were commu-
nity control health organisations (27%), government
health departments (27%), shared government and com-
munity (36%), and private practice and community
(10%). Eight initiatives were conducted onsite at the
local PHC centre or general practice [20-23,26-29], four
were visiting outreach services [24,25,31,32] and one ini-
tiative was a home-based care model [30]. For a sum-
mary of key study elements see Table 2. The source and
level of program funding was not always clear. It would
seem, however, that in most cases the initiative involved
additional funding and additional resources.
HbA1c levels were reported by 12 of the 13 studies.
Schraer and colleagues [25] reported incidence rates of
lower extremity amputation (Table 3). In addition to
reporting HbA1c, McDermott et al. [29] reported the
number of persons hospitalised for a diabetes-related
reason and the number of diabetes-related admissions.
A statistically significant improvement in HbA1c levels
was reported by five of the 12 studies to report HbA1c,
and seven studies reported no significant change pre –
post cohort or compared with control or less-intensive
management. McDermott et al. [29] reported a decrease
in the proportion of persons hospitalised and episodes of
diabetes-related hospitalisations among the group re-
ceiving the intervention. The specialist foot program ap-
peared successful with a 59% reduction in the incidence
of lower limb amputation between 1996 and 1998 com-
pared to 1999 and 2000 [25].
Discussion
The aim of the review was to assess the literature on the
impact of primary health care initiatives for type 2
diabetes on health outcomes of Indigenous populations.
We sought to do this by exploring consistency in find-
ings of studies that related system or service level attri-
butes of primary health care to improvements in
objective diabetes health outcome measures. This would
shed light on what might be contributing at a service or
system level to what works to improve the quality of pri-
mary care in Indigenous populations. Since the introduc-
tion of evidence-based care guidelines, 13 studies
published from 2001 that met the inclusion criteria were
found. All four countries had published two or more
studies. Six of 13 interventions reported lowered HbA1c
levels or reduced diabetes-related hospitalisations or the
incidence of amputation. All of the interventions were
complex and varied across all of the elements of interest.
This is to be expected, given the differences in health
policies for Indigenous people across the four countries
and the epidemiology of diabetes.All six interventions that achieved an improvement in
health outcome were multi-faceted in nature, delivering
more than one component. For example, the Australian
study that implemented evidence-based guidelines for dia-
betes in Torres Strait Islander health centres [29] included
the establishment of population registers, recall and re-
minder systems, and patient care plans. The model was
also supported by the necessary administrative and clinical
resources to implement the guidelines and training and
development of the workforce. Interventions to improve
diabetes management in the primary care setting that ad-
dress a combination of elements have been found to be
more successful in achieving health outcomes than those
that only focus on one element, such as a training pro-
gram for health professionals [33]. Ten of 13 studies in
this review were multifaceted interventions and six of
these achieved an improvement in an objective health out-
come measure.
Interventions included in this review were designed to
introduce a health system, clinical system or service level
program. It was not clear that the ‘level of intervention’
was predictive of a particular outcome. Of the five stud-
ies that implemented system level interventions, two
achieved a reduction in HbA1c. One of these, an IHS
initiative [22], involved the transfer of funds to Indigen-
ous health organisations or tribal groups, whilst NZ Care
Plus [26] financed local primary care providers to em-
ploy four practice nurses and provide all clients with a
wellness plan and free health consultations [27]. Whilst
the NZ initiative was unique amongst the five health sys-
tem interventions, the IHS approach that involved the
transfer of funds to Indigenous organisations was the
focus of two other interventions [20,23]. A fifth study
that offered people with diabetes a free annual health
check [27] did not achieve a reduction in HbA1c.
Generally it was found that a strong primary health
care system within a country is associated with lower
rates of all-cause, premature and chronic disease-related
mortality within the population [34]. The role of primary
health care within the overall health system can be
strengthened by re-orienting investment to include more
primary care services and/or more practitioners per
capita [35]. Mainstream policy reforms may increase ser-
vice use by those population groups that have a greater
ability to maximise the opportunity while the more vul-
nerable harder to reach groups may be less likely to
benefit [36]. The Indigenous specific health system inter-
ventions that did not achieve an improved health out-
come identified a range of impediments. These included
implementation challenges pertaining to remoteness, the
quality of communications infrastructure and transpor-
tation, the willingness of patients to participate in more
comprehensive care, governance arrangements [20] and
recruiting and retaining staff [20,23]. Bailie et al. [20]









Bailie et al. 2004 [20] HS Shared PHC Remote Clinic HbA1c 7/9 Unchanged
Australia
Bailie et al. 2007 [21] CS Shared PHC Remote Clinic HbA1c 6/9 Improved
Australia
Roubideaux et al. 2008 [23] HS Shared PHC, Hospitals Urban & rural Clinic HbA1c 6/9 Unchanged
US
Wilson et al. 2005 [22] HS Shared PHC, Tribal Clinics, Hospitals Remote & regional Clinic HbA1c 8/9 Improved
US
Kenealy et al. 2010 [26] HS Private & CC GPs Urban & rural Clinic HbA1c 6/9 Improved
NZ
Smith et al. 2011 [27] HS Govt. GPs Urban Clinic HbA1c 8/8 Unchanged
NZ
Simmons et al. 2003 [28] CS CC PHC Rural Clinic HbA1c 5/9 Improved
Australia
Schraer et.al. 2003 [25] CS Shared Specialist referral service,
PHC




Ramesh et al. 2008 [24] CS Shared Specialist referral service,
PHC
Remote & regional Out-reach HbA1c 8/8 Improved
US
Virani et al. 2006 [32] CS CC Mobile van Remote & rural Out-reach HbA1c 4/9 Unchanged
Canada
McDermott et al. 2001 [29] CS Govt. PHC’s Remote Clinic HbA1C 5/9 Unchanged
Australia % hospitalised Improved
% hosp. episodes Improved




Ralph-Campbell et al. 2006 [31] SP Govt. PHCs Regional centres in rural
areas
Out-reach HbA1c 6/9 Unchanged
Canada
aNumber of quality criteria met compared to total number of criteria.
bOutcome is reported as unchanged if the p value is insignificant, see results Table 3.















Table 3 Study results of health outcomes (HbA1c, diabetes–related hospitalisation, primary endpoints)
Initiative, study design
(first author and date published)
Result reported Baseline
(or basic service level) [n]a
Final visit or comparison
group [n]a
Difference 95% Confidence interval or P
value
CCT, pre – post cohort HbA1c mean mmol/L% (CI) 9.0 (8.6, 9.4) [n = 137] 8.8 (8.3, 9.2)
[n = 146]
−0.2 0.23 for trend
(Bailie et al. 2004) [20]
Improved care coordination,
cohort follow-up
HbA1c mean mmol/L% (CI) 9.3 (8.8, 9.8) [n = 295] 8.9 (8.6, 9.3)
[n = 252]
−0.4 −0.7, –0.1
(Bailie et al. 2007) [21]
IDERP – IHS, cross sectional HbA1c mmol/L% (% patients <7.0) not reported not reported OR = 1.1 0.8, 1.7
(Roubideaux 2008)b [23]




(Wilson et al. 2005) [22]
Care Plus, open prospective cohort HbA1c mean mmol/L% (CI)c 8.1 (8.0, 8.2) [n = 354] 7.2 (6.7, 7.5)
[n = 3]
−0.9 <0.05 (based on CIs)
(Kenealy et al. 2010) [26]
Get Checked, pre – post cohort HbA1c mean mmol/L% (SD) 8.0 (1.6) [n = 298] 8.0 (1.6)
[n = 298]
0 Not reportedd
(Smith et al. 2011) [27]
Integrated diabetes service,
pre – post cohort
HbA1c mean mmol/L% (SD) 10.4 (2.2) [n = 30] 7.9 (1.9)
[n = 30]
−2.5 <0.001
(Simmons et al. 2003) [28]
Foot program – IHS, pre –
post incidence study
(Schraer et al. 2003) [25]
Amputation incidence
(per 1000 person years)
16.4 (1342 person years) 6.8 (1628 person years) −59% 0.021
Special diabetes program,
repeated cross section
HbA1c mean mmol/L% 8.4 [n = 1394] 7.4 [n = 1839] −1 <0.001
(Ramesh et al. 2008) [24]
SLICK, pre – post cohort HbA1c Mean mmol/L% 8.12 [n = 285] 8.01 [n = 285] −0.11 0.176
(Virani et al. 2006) [32]
Evidence based management
of diabetes, cluster randomised trial
HbA1c mmol/L% (% <7) not reported [n = 555] IG = 22 CG = 20
[n = 678]
RR: 1.26e 0.219
(McDermott et al. 2001) [29] Persons hospitalised for diabetes
reasons (%)
IG = 20 CG = 22 [n = 555] IG = 12 CG = 20
[n = 678]
IG = –8% CG = –2% IG = 0.012
CG = 0.514f
Diabetes hospital episodes (%) IG =23 CG =30 [n = 555] IG =19 CG =29
[n = 678]
















Table 3 Study results of health outcomes (HbA1c, diabetes–related hospitalisation, primary endpoints) (Continued)
Hypertension management,
randomised unblinded control trial
HbA1c mean mmol/L% (SD) IG = 7.9 (1.9)g CG = 7.7 (1.8)
[n = 99]
IG 7.8 (2.1) CG 7.7 (1.9) [n = 95] IG = –0.1 (1.7) CG = –0.0
(1.3)
>0.05h
(Tobe et al. 2006) [30]
DOVE, pre – post cohort HbA1c mean mmol/L% (CI) 7.4 (7.0–7.8) [n = 94] 7.7 (7.4–7.9)
[n = not reported]
+0.3 >0.05 (based on CIs)
(Ralph-Campbell et al. 2006) [31]
Notes:
aNumber of Indigenous participants.
bRoubideaux et al. [23] compared patient health outcomes of primary health care services awarded 1) service recognition of educational or integrated quality and 2) those that were in developmental stages of
achieving an integrated service. Those in stage 2, more advanced stages of development, were 10% more likely to have a higher proportion of patients with a HbA1c < 7. This finding was not a statistically
significant finding.
cHbA1c predicted from multivariate model.
dSmith et al. [27] report a net effect (measured from baseline to, at 5 years) of 0.03% increase in HbA1c for Maori and a 0.18% increase for European, both adjusted for age and gender.
eInterpreted as: Individuals at intervention sites are 26% more likely to have a HbA1c of <7 mmol% compared to those at control sites.
fP value for difference between intervention and control group not reported.
gTypographical error in Table 2 of original study manuscript reporting HbA1c level of intervention at baseline.
hSame result for comparison between groups over time and within group over time.
CCT – Coordinated Care Trial; CI – confidence interval; IDERP – Integrated Diabetes Education Recognition Program; IG – intervention group; IHS – Indian Health Service; mmol/L – millimoles per litre; SLICK – Screening
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to overcome challenges for sustained improvement in
health outcomes in the Indigenous community con-
trolled health sector.
Clinical system interventions were implemented by six
of the thirteen reviewed studies. They each introduced a
systematic evidence-based approach to diabetes manage-
ment in local PHC settings and also professionally devel-
oped their workforce. For example, the Special Diabetes
Program for Indians [24] comprised multi-disciplinary
diabetes outreach teams that implemented clinical gov-
ernance initiatives. This involved the introduction of
evidence-based care guidelines, quality assurance pro-
grams, patient registers, and supporting and profession-
ally developing the workforce. The program also
received referrals from all IHS facilities and maintained
a regional diabetes register. Factors of successful imple-
mentation of clinical governance have shown to include
professional leadership, local relevancy, the ability for
staff to review their own performance and readily ac-
cessible information on health care practice [37,38]. Four
of the six clinical system interventions in this review
achieved an improvement in the objective health out-
come measure of interest.
There was a range of governance structures of the pri-
mary health care services that participated in the inter-
ventions. The majority of interventions were located in a
primary health care service that had shared governance
arrangements between the government and an Indigen-
ous community controlled health service [20-25]. Three
interventions were implemented in Indigenous commu-
nity controlled health services [28,30,32] and the same
number within government services [27,29,31]. One
intervention was implemented in a primary care service
that had a shared governance arrangement between an
Indigenous community board and a private practice
group [26]. Indigenous peoples desire to have control
over their own health has been expressed through the
establishment of community-governed or controlled
health services. Due to the diversity of where Indigenous
people live and their health and well-being needs, it is
likely that a range of governance arrangements within
countries would be ideal [39]. There are multiple gov-
ernance structures [40] and three of those present in this
review. Four of the interventions in this study that oc-
curred within primary care services with a shared gov-
ernance structure achieved an improved health outcome
measure. All three interventions within a community
controlled setting did not achieve an improved health
outcome measure of interest to this review.
Limitations
Whilst we believed this study question could have pro-
vided insight on important system or service levelattributes of primary health care that lead to improved
related health outcomes, the limitations of this study re-
quire these analyses to be interpreted with caution. Dif-
ferences in health care policies relating to Indigenous
peoples health and well-being and to the provision of
primary health care vary between the countries of inter-
est [41,42]. Even to the extent of within country differ-
ences, such as in Canada, where First Nations people
have more access to enhanced program funding from
Health Canada compared to those living in the territor-
ies [5]. These policies would fundamentally impact on
access to primary care services differently for each popu-
lation group, that could lead to better or poorer health
outcomes measured in this study.
Vast differences in the setting, the population, the tar-
get group and the outcome measures limited the com-
parative value of the interventions. It is also not possible
to attribute a change in health outcome solely to the
intervention as external factors may have contributed
and likely to a greater extent without participant ran-
domisation or analysis that adjusts for confounding.
The study inclusion criteria deliberately sought an ob-
jective health outcome measure in determining the
scope of the review. This excluded studies that reported
subjective outcomes, which may have been otherwise
well designed, omitting their contribution to the synthe-
sised findings of this review. In addition, the number of
eligible studies may have been limited by excluding gray
literature in search strategy.Conclusions
A small number of published studies that measure the
impact of diabetes management in a PHC setting on
health outcomes among the four selected Indigenous
population groups were found. Across these studies
there were no consistent patterns of health system or
service level attributes. However, the results do provide
insight on the characteristics, quality and impact on
health outcomes of the interventions being implemented
in the four countries to address the escalating prevalence
of type 2 diabetes in their Indigenous populations. In the
last 15 years, Australia has predominantly invested in es-
tablishing and improving the ability of their clinical sys-
tems to manage chronic diseases including T2DM. Since
2010, efforts in NZ have involved increasing Maori peo-
ples access to mainstream services. Canada’s response
has been to provide service programs and build the cap-
acity of the clinic system in hard to reach locations. The
US has spread its efforts across building both the PHC
system and the clinical system. All interventions in this
review that had a positive impact on health outcomes
supported the development of multiple areas, as op-
posed to having a single focus.
Gibson and Segal BMC Health Services Research  (2015) 15:154 Page 12 of 13Descriptive/observational studies are the largest con-
tributors to the evidence, possibly because they are more
ethically acceptable to the participating communities
and less time and resource intensive than comparable
cohort studies and randomised trials. Failure to describe
participants who withdrew from the intervention was a
weakness in the quality of the observational studies.
Characteristics of participants who withdrew from the
intervention are a valuable finding that can help inform
the appropriateness of future interventions. Mixed
methods research that imparts perspectives of policy
makers and funders, service providers and patients in
addition to objective health outcomes could provide a
more comprehensive understanding of how PHC attri-
butes may impact on health outcomes. Conducting
rigorous PHC research in real settings, especially at the
health or clinical system level is difficult. However, this
is an important question for policy makers, and further
high quality research is needed to contribute to the evi-
dence base for informed decision making.
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